Compare CDZI & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CDZI | NBY |
|---|---|---|
| Founded | 1983 | 2000 |
| Country | United States | United States |
| Employees | 31 | N/A |
| Industry | Water Supply | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 413.8M | 31.6M |
| IPO Year | N/A | 2007 |
| Metric | CDZI | NBY |
|---|---|---|
| Price | $4.78 | $1.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 523.8K | 409.8K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.42 |
| EPS | N/A | ★ 0.76 |
| Revenue | N/A | ★ $370,000.00 |
| Revenue This Year | $23.80 | N/A |
| Revenue Next Year | $125.51 | N/A |
| P/E Ratio | ★ N/A | $2.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.50 | $0.43 |
| 52 Week High | $6.96 | $19.95 |
| Indicator | CDZI | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 43.78 | 57.82 |
| Support Level | $4.46 | $1.01 |
| Resistance Level | $5.75 | $2.52 |
| Average True Range (ATR) | 0.25 | 0.26 |
| MACD | -0.00 | 0.11 |
| Stochastic Oscillator | 19.82 | 96.45 |
Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, generating maximum revenue engaged in providing water filtration solutions for impaired or contaminated groundwater sources.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.